Valuation: Artivion, Inc.

Market Cap 1.32B 1.14B 1.07B 978M 1.84B 126B 1.87B 12.55B 4.92B 63.09B 4.96B 4.86B 210B P/E 2026 *
452x
P/E 2027 * 67.8x
Enterprise Value 1.32B 1.14B 1.07B 978M 1.84B 126B 1.87B 12.55B 4.92B 63.09B 4.96B 4.86B 210B EV / Sales 2026 *
2.7x
EV / Sales 2027 * 2.44x
Free-Float
89.13%
Yield 2026 *
-
Yield 2027 * -
1 day-2.34%
1 week-3.22%
Current month-0.91%
1 month+10.36%
3 months+11.65%
6 months-34.10%
Current year-41.71%
1 week 25.79
Extreme 25.7875
28.26
1 month 22.83
Extreme 22.83
28.29
Current year 19.16
Extreme 19.16
46.84
1 year 19.16
Extreme 19.16
48.25
3 years 12.16
Extreme 12.1582
48.25
5 years 9.64
Extreme 9.64
48.25
10 years 9.64
Extreme 9.64
48.25
Manager TitleAgeSince
Chief Executive Officer 59 2014-09-01
Director of Finance/CFO 53 2023-12-03
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 2003-11-30
Director/Board Member 66 2003-11-30
Director/Board Member 61 2012-04-30
Date Insider Type Main position Quantity % Market Cap.
6/2/26 Others

Director

-12,650 0.0261%
3/2/26 Free

Chief Executive Officer

134,835 0.2816%
2/23/26 Sell

Compliance Officer

24,832 0.0524%
Change 5-day change 1-year change 3-year change Capi.($)
-2.95%-3.22%-38.12%+60.34% 1.32B
+0.89%+1.07%-17.58%+3.37% 187B
+2.01%+2.33%-4.36%+6.71% 112B
+1.13%+4.76%+11.13%+72.72% 61.15B
+2.38%+6.38%+35.52%+59.33% 54.39B
+0.94%+4.47%-7.63%-35.86% 48.17B
+3.75%+0.02%+12.18%-22.90% 31.98B
-3.96%-16.58% - - 30.91B
+0.75%+2.13%+47.85%-11.22% 24.92B
-0.10%+1.51%-2.26%+3.93% 23.15B
Average +0.32%+1.78%+4.08%+15.16% 57.41B
Weighted average by Cap. +0.93%+2.17%-0.08%+11.93%

Financials

2026 *2027 *
Net sales 490M 424M 397M 363M 683M 46.76B 694M 4.65B 1.83B 23.39B 1.84B 1.8B 77.91B 543M 470M 439M 401M 757M 51.77B 768M 5.15B 2.02B 25.9B 2.04B 1.99B 86.27B
Net income 2.8M 2.42M 2.27M 2.07M 3.9M 267M 3.96M 26.57M 10.43M 134M 10.51M 10.28M 445M 24.19M 20.94M 19.58M 17.89M 33.72M 2.31B 34.24M 230M 90.08M 1.15B 90.85M 88.86M 3.84B
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change Volume
26-08-10 $26.36 -2.82% 248,880
26-08-07 $27.12 +2.07% 1,081,661
26-08-06 $26.57 +1.53% 1,139,504
26-08-05 $26.17 -2.71% 964,007
26-08-04 $26.90 -2.07% 572,939
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
27.12USD
Average target price
42.02USD
Spread / Average Target
+54.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AORT Stock